pyrroles has been researched along with Abdominal Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demidova, NV; Kirillova, IG; Markelova, EI; Misiyuk, AS; Novikova, DS; Popkova, TV; Udachkina, HV | 1 |
| Barrett, PH; Chan, DC; Nguyen, MN; Ooi, EM; Watts, GF | 1 |
| Byrne, CD; Chipperfield, AJ; Clough, GF; Gamble, J; Krentz, AJ; L'Esperance, V; Turzyniecka, M; Walter, L | 1 |
2 trial(s) available for pyrroles and Abdominal Obesity
| Article | Year |
|---|---|
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein C-III; Atorvastatin; Cholesterol, VLDL; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Heptanoic Acids; Humans; Male; Middle Aged; Obesity, Abdominal; Pyrroles; Triglycerides | 2010 |
Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment.
Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Female; Heptanoic Acids; Humans; Hyperemia; Hyperinsulinism; Insulin Resistance; Male; Microcirculation; Middle Aged; Obesity, Abdominal; Pyrroles; Risk Factors; Vasodilation | 2011 |
1 other study(ies) available for pyrroles and Abdominal Obesity
| Article | Year |
|---|---|
Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.
Topics: Adiposity; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Female; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity, Abdominal; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Waist Circumference | 2019 |